Impurity results batches

TABLE I Impurity Results from Three Validation Batches Using the New Suppliers Drug Substance. Specifications Are <0.1%... 

Uneven wash application will result in decreased efficiency for removing impurities from batch. 

If they still contain volatile impurities resulting from the reaction they come from, they can be recycled only for this reaction. In this case, the impurities should be identified and their possible impact on the reaction evaluated. In tables 13.21.1.7 and 13.21.1.8 we have summarized possible specifications for a fresh batch of ethyl acetate used for a defined chemical reaction and those for the recycled solvent. 

Jote 2. We have also carried out this synthesis in ethanol as a solvent but the results were not reproducible. Although a series of experiments with zinc powder from one flask gave reasonable results (50-78% yields), a new flask with the same batch number gave low yields of impure products. The main impurity was probably the non-conjugated diene, H2C=CH-CH2-CH=CH-CH3, possibly resulting from reduction of the 1,2,4-triene by the zinc. The... 

The same is true if another situation is considered if in a batch process a sample is taken before and after the operation under scrutiny, say, impurity elimination by recrystallization, and both samples are subjected to the same test method, the results from, say, 10 batch processes can be analyzed pairwise. If the investigated operation has a strictly additive effect on the measured parameter, this will be seen in the t-test in all other cases both the difference Axmean and the standard deviation will be affected. 

The GMT in human serum reacts most rapidly with Y-glutamyl-p-nitroanilide at pH 8.2. The same activity is found in 2-amino-2-methylpropane-l 3 diol, diethanolamine, triethanolamine and tris buffers. Magnesium ions have no effect on the activity but favor the solubilization of the substrate. Bondar and Moss (54) found that free glutamate, due to elevated serum glutamate concentrations or glutamate released by substrate breakdown, increases the apparent GMT activity. They concluded that the assay should be performed in the presence of 1.0 vM/1 glutamate in order to reduce the possibility of falsely elevated results. This was not observed by others. Rowe and co-workers have indicated that certain batches of p-nitroanilide substrate contain impurities which may reduce GMT activity and increase the values ( ). Huesby and Stromme (56) confirmed the presence of such impurities and recommended pyridine extraction for substrate purification. 

The validation process begun in Phase I is extended during Phase II. In this phase, selectivity is investigated using various batches of drugs, available impurities, excipients, and samples from stability studies. Accuracy should be determined using at least three levels of concentration, and the intermediate precision and the quantitation limit should be tested. For quality assurance evaluation of the analysis results, control charts can be used, such as the Shewart-charts, the R-charts, or the Cusum-charts. In this phase, the analytical method is refined for routine use. 

Three products (PI, P2, aod P3) and two slop cuts (SI and S2) are produced. The average composition of the products are 95 mole percent. The PI product is mostly the lightest component (component 1). The P2 product is mostly intermediate component (number 2) with some impurities of both the light and the heavy components. The final product P3 is what is left in the still pot and on the trays. The times to produce the various products and slop cuts are given in the results shown in Table 5.14. The total time for the batch distillation in this example is 6.4 hours. 

For organic impurities summaries of all experiments used to detect impurities should be available and should include comparisons between batches produced during development, those from the proposed commercial process, and results from any stress testing. Any differences between these should be discussed. Studies used to identify and qualify impurities should also be discussed. The ICH has published guidelines depending on... 

During the course of chemical development, impurity profiles in drug substances may change due to changes in synthetic route and changes in the size of the batch. ICH guidelines for Impurities in New Drug Substances (ICH Q3A), require that impurity test results for... 

For many years, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) methods have been used as an essential tool to determine the hydrodynamic size, monitor product purity, detect minor product or process-related impurities, and confirm batch-to-batch consistency of protein and antibody products. ITowever, gel-based techniques have several limitations, such as lack of automation, varying reproducibility, and a limited linear range. SDS-PAGE is also labor-intensive and generates large volume of toxic waste. Most importantly, the technique does not provide quantitative results for purity and impurity determination of proteins and antibodies. 

PLATE I Determination of the enantiomeric purity of active pharmaceutical ingredient (main compound = MC, peak I is the enantiomeric impurity). Conditions lOOmM sodium phosphate buffer pH = 3.0, lOmM trimethyl -cyclodextrin, 60 cm fused silica capillary (effective length 50 cm) X 75 pm I.D., injection 10 s at 35 mbar, 25°C, 20 kV (positive polarity) resulting in a current of approximately lOOpA, detection UV 230 nm. The sample solution is dissolved in a mixture of 55% (v/v) ethanol in water. (A) Typical electropherogram of an API batch spiked with all chiral impurities, (B) overlay electropherograms showing the selectivity of method toward chiral and achiral impurities, a = blank, b = selectivity solution mixture containing all known chiral and achiral compounds, c = API batch, d = racemic mixture of the main compound and the enantiomeric impurity. 

Provided the reaction mixture is prepared under stringent conditions, such that reaction of the dianions with impurities (e.g., water) is prevented, the polymer chains can grow until the monomer is completely consumed. If another batch of styrene is added, the living polymer can grow further. If, finally, a chain breaker is added (e.g., proton donor), a dead polymer results. 

---